1Guangwen Yuan, Lingying Wu, Manni Huang, et al.A phase II study ofconcurrent chemo- radiotherapy with weekly nedaplatin in advancedsquamous cell carcinoma of the uterine cervix[J].Radial Oncol. 2014,9(I):55.
5Sasaki Y, Ohta T,Tamura T, et al. A case report pulmonary adeno- carcinorm responding to (glycolato-O') diammineplafinum( Ⅱ ), a new plafintma complex[J]. Jpn J Clin 0nco1,1987,17(3) :285.
6Ota K. Nedaplatin[J]. Can To Kagaku Ryoho,1996,23(3):379.
7l_oh GW, 'ling IS, Ensom MH. A systematic review of limited sampling strategies far platinum agents used in cancer chemotherapy[ J ]. Clin Pharmacokinet, 2007,46(6) :471.
8Sasaki Y, Amano T, Mofita M, et al. Phase I study and pharmaeologi- cad analysis of cis-diammine(glyeolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusiou[J]. Cancer Res, 1991 ,51(5) : 1472.
9Matsumoto Y, Ishlko O, Nakagawa, E, et al. Phannacnetics and phammcynamics of serum platinum of gynecologic cancer patients treated with nedaplatin[J]. Oncol Rep,2001,36(8) :1269.
10Niioka T, Uno T, Yami-Furukori N, et 81. Phanmeekinctics of lowdose nedaplatin and validation of AUC prediction in patients with non-small-eel hmg eareinmna[J]. Cancer Chemoter Pharmaeol, 2007,59 (5) :575.
